ASPEN Financial Statements From 2010 to 2024
| LDZU Stock | EUR 8.55 0.05 0.59% |
Check ASPEN PHARUNADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ASPEN PHARUNADR's main balance sheet or income statement drivers, such as , as well as many indicators such as . ASPEN financial statements analysis is a perfect complement when working with ASPEN PHARUNADR Valuation or Volatility modules.
ASPEN |
ASPEN PHARUNADR 1 Company Return On Asset Analysis
ASPEN PHARUNADR's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current ASPEN PHARUNADR Return On Asset | 0.0499 |
Most of ASPEN PHARUNADR's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ASPEN PHARUNADR 1 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, ASPEN PHARUNADR 1 has a Return On Asset of 0.0499. This is 100.57% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all Germany stocks is 135.64% lower than that of the firm.
ASPEN PHARUNADR 1 Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ASPEN PHARUNADR's current stock value. Our valuation model uses many indicators to compare ASPEN PHARUNADR value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ASPEN PHARUNADR competition to find correlations between indicators driving ASPEN PHARUNADR's intrinsic value. More Info.ASPEN PHARUNADR 1 is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ASPEN PHARUNADR 1 is roughly 1.90 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ASPEN PHARUNADR's earnings, one of the primary drivers of an investment's value.About ASPEN PHARUNADR Financial Statements
ASPEN PHARUNADR stakeholders use historical fundamental indicators, such as ASPEN PHARUNADR's revenue or net income, to determine how well the company is positioned to perform in the future. Although ASPEN PHARUNADR investors may analyze each financial statement separately, they are all interrelated. For example, changes in ASPEN PHARUNADR's assets and liabilities are reflected in the revenues and expenses on ASPEN PHARUNADR's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ASPEN PHARUNADR 1. Please read more on our technical analysis and fundamental analysis pages.
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa. ASPEN PHAR is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in ASPEN Stock
ASPEN PHARUNADR financial ratios help investors to determine whether ASPEN Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ASPEN with respect to the benefits of owning ASPEN PHARUNADR security.